Advertisement US healthcare spending to double by 2017 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

US healthcare spending to double by 2017

The National Health Expenditure Accounts Projections Team, Health Affairs, has predicted that the healthcare spending in the US will hit $4.3 trillion by 2017.

US health-care spending which was $2.2 trillion in 2007 is predicted to grow annually by about 6.7% for the next decade. GDP by contrast is expected to rise by 4.7% annually, while inflation is expected to increase by 2.4%. The US government’s Centers for Medicare and Medicaid Services predicts that healthcare spending will account for 19.5% of the US gross domestic product by 2017, up from 16.3% in 2007.

The National Health Expenditure Accounts Projections Team forecasts that Medicaid will increase at around 7.9% annually, before reaching $717 billion in 2017, accounting for up to 17% of US healthcare expenditure. By 2017, the Medicare bill – $427 billion in 2007 – is predicted to reach $884 billion, making up more than 20% of all US healthcare spending, while Medicaid is expected to register higher rate than overall healthcare spending.

But growth in private healthcare spending is predicted to decline to 5.9% more per year by 2017, after reaching a high mark of 6.6% in 2009. The drugs bill is also expected to rise to $516 billion by 2017. The revised treatment guidelines are expected to create greater demand in some therapeutic classes (such as cholesterol and high blood pressure).